A comparison of patient reported outcomes in rheumatoid arthritis treated by tofacitinib versus methotrexate
Background: Rheumatoid arthritis (RA) is a chronic and debilitating autoimmune disease characterized by systemic inflammation, persistent synovitis, and joint destruction. 1 Patients and physicians rate RA disease differently — while physicians focus on RA-specific clinical and radiographic outcomes...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Eldaghayes Publisher
2023-08-01
|
| Edice: | National Journal of Physiology, Pharmacy and Pharmacology |
| Témata: | |
| On-line přístup: | http://www.ejmanager.com/fulltextpdf.php?mno=93261 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|